Tech Company Financing Transactions
Kmia Funding Round
Aberdare Ventures, Alta Partners and Forward Ventures participated in a $31 million Series C funding round for Kmia. The round was announced on 8/23/2006.
Transaction Overview
Company Name
Announced On
8/23/2006
Transaction Type
Venture Equity
Amount
$31,000,000
Round
Series C
Investors
Proceeds Purpose
The company plans to use the proceeds to advance its lead clinical compound, KC706, through initial Phase II clinical trials and to progress additional Kmia programs into the clinic.
Company Information
Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
5871 Oberlin Drive 100
San Diego, CA 92121
USA
San Diego, CA 92121
USA
Phone
Website
Email Address
Overview
Kmia discovers and develops novel small molecule therapeutics. Kmia focuses on high value disease targets that are validated, but not yet addressed by safe and effective non-injectable drugs.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Lewis Shuster
Chief Medical Officer
Michael Hodges
Vice President
Jan Lundstrom
Vice President
Stephen Miller
VP - Bus. Development
Martin Emanuele
VP - Finance
Richard Canote
Browse more venture capital transactions:
Prev: 8/23/2006: Inlet Technologies venture capital transaction
Next: 8/23/2006: Kemia venture capital transaction
Share this article
Where The Data Comes From
We do our best to record all VC transactions involving tech companies. VC investment data records on this site come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs